BELITE BIO INC
BLTE·07782B104·US·ADR·Healthcare - Biotechnology-13D/G
BLTE (BELITE BIO INC) is held by 41 institutional investors as of Q1 2026. Largest holders: UBS Group AG ($122.5M), RTW INVESTMENTS, LP ($114.1M), MILLENNIUM MANAGEMENT LLC ($90.9M). Net institutional sentiment: Bullish.
41
Holders
(4 Elite)
$575.4M
Total Value
67% (43)
Consensus
29 buying - 14 selling
13F: Insider & Congress:
Who's Trading
InsiderSPScholl Hendrik PeterSell $14KJun 18, 2026
InsiderSPScholl Hendrik PeterSell $542KJun 18, 2026
InsiderSPScholl Hendrik PeterSell $707KJun 18, 2026
InsiderSPScholl Hendrik PeterSell $175KJun 18, 2026
InsiderSPScholl Hendrik PeterSell $14KJun 18, 2026
InsiderSPScholl Hendrik PeterSell $283KJun 16, 2026
InsiderSPScholl Hendrik PeterSell $108KJun 16, 2026
InsiderSPScholl Hendrik PeterSell $438KJun 16, 2026
ActivistYLYu-Hsin Lin3.1%May 14, 2026
ActivistDGDarwin Global Management, Ltd.8.1%Feb 17, 2026
Top Holders
Showing 1-20 of 47
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
413 holders · $666.6B
413 holders · $186.3B
394 holders · $391.3B
392 holders · $97B
391 holders · $123.5B
391 holders · $147B
389 holders · $76.8B
385 holders · $208.9B
381 holders · $254.9B
380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer